Enkephalin-processing oligopeptidases in cobra venom: Inhibition by thiorphan and bestatin reveals co-operative actions

Toxicon

Volumn 36, Issue 5, 1998, Pages 719-728

  Anderson, Lois ^a   Bussler, Brandon ^a   Martins, Helena ^a   Dufton, Mark ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BESTATIN; PEPTIDASE; SNAKE VENOM; THIORPHAN;

ARTICLE; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME SUBSTRATE; NONHUMAN; PRIORITY JOURNAL; SNAKE; TOXIN ANALYSIS;

AMINOPEPTIDASES; ANIMALS; COBRA; COBRA VENOMS; DRUG SYNERGISM; ENKEPHALINS; LEUCINE; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; SUBSTRATE SPECIFICITY; THIORPHAN;

ATRA; NAJA ATRA; NAJA NAJA; SERPENTES;

EID: 0031813780     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(97)00134-7     Document Type: Article

References (11)

1. Anderson, L. and Dufton, M. J. (1997) The action of Taiwan cobra venom on enkephalin: A useful assay for oligopeptidase content. Toxicon 35, 1113-1123.
2. Anderson, L. and Dufton, M. J. (1998) Oligopeptidases. In Snake Venom Enzymes, ed. G. S. Bailey. Alaken Inc., in press.
3. Bjarnason, J. B. and Fox, J. W. (1995) Snake venom metalloendopeptidases: Reprolysins. In Methods in Enzymology, Vol. 248, Proteolytic enzymes: Aspartic and Metallo Peptidases, ed. A. J., Barrett, pp. 345-368. Academic Press, San Diego.
4. Boumrah, D., Suckling, C. J. and Dufton, M. J. (1993) Characteristics of the peptidase activity contained in Taiwan cobra (Naja naja atra) venom. Toxicon 31, 1293-1303.
5. Iwanaga, S. and Suzuki, T. (1979) Enzymes in snake venoms. In Snake Venoms, Handbook of Experimental Pharmacology, Vol. 52, ed. C. Y. Lee, pp. 61-158. Springer-Verlag, New York.
6. Kenny, J. (1993) Endopeptidase 24.11: Putative substrates and possible roles. Biochemical Society Transactions 21, 663-668.
7. Kenny, J. (1986) Cell surface peptidases are neither peptide- nor organ-specific. Trends in Biochemical Science 11, 40-42.
8. Rich, D. H., Monn, B. J. and Harbeson, S. (1984) Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes. Journal of Medicinal Chemistry 27, 417-422.
9. Roques, B. P., Noble, F., Crine, P. and Fournie'-Zaluski, M. C. (1995) Inhibitors of Neprilysin: Design, pharmacological and clinical applications. In Methods in Enzymology, Vol 248, Proteolytic enzymes: Aspartic and metallopeptidases, ed. A. J. Barrett, pp. 263-283. Academic Press, San Diego.
10. Roques, B. P., Beaumont, A., Dauge, V. and Fournie'-Zaluski, M. C. (1993) Peptidase inactivation of enkephalins; Design of inhibitors and biochemical, pharmacological and clinical applications. In Opioids I, Handbook of Experimental Pharmacology, Vol 104/I, ed. A. Herz, pp. 547-584. Springer-Verlag, Berlin.
11. Schwartz, J. C., Bouthenet, M., Giros, B., Gros, C., Lloren-Cortes, C. and Pollard, H. (1991) Neuropeptidases and neuropeptide inactivation in the brain. In Volume Transmission in the Brain: Novel mechanisms for neural transmission, ed. K. Fuxe and L. F. Agnati, pp. 381-394. Raven Press Ltd., New York.